摘要 |
<p>Disclosed herein are methods for controlling the activity of hypoxia- inducible transcription factor 1 -alpha (HIF- la) and diseases, conditions, or syndromes related thereto, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. Further disclosed are pharmaceutical compositions comprising HIF- la prolyl hydroxylase inhibitors useful in treating diseases, conditions, and/or syndromes related thereto the activity of HIF-I a.</p> |